Compare Stocks → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:BSTGNASDAQ:INVONASDAQ:MOTSNASDAQ:SINT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSTGBiostage$4.45$4.45$4.45▼$4.45$61.78M-1.021,847 shsN/AINVOINVO Bioscience$0.98-16.2%$1.06$0.50▼$10.50$2.69M1.453.02 million shs596,319 shsMOTSMotus GI$0.08$0.50$0.05▼$23.40$402K1.31.37 million shs79,947 shsSINTSintx Technologies$0.04$0.09$0.02▼$1.82$878K1.4622.13 million shs15.77 million shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSTGBiostage0.00%0.00%0.00%0.00%-25.83%INVOINVO Bioscience-16.23%-35.52%-5.76%-5.76%-87.03%MOTSMotus GI+3.90%+14.29%-81.47%-91.95%-99.34%SINTSintx Technologies-5.43%-8.50%-25.76%-87.69%-97.68%“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSTGBiostageN/AN/AN/AN/AN/AN/AN/AN/AINVOINVO BioscienceN/AN/AN/AN/AN/AN/AN/AN/AMOTSMotus GI1.2042 of 5 stars3.53.00.00.00.60.00.6SINTSintx TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSTGBiostageN/AN/AN/AN/AINVOINVO BioscienceN/AN/AN/AN/AMOTSMotus GI3.00Buy$28.8835,993.75% UpsideSINTSintx Technologies2.00HoldN/AN/ACurrent Analyst RatingsLatest MOTS, INVO, BSTG, and SINT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/5/2024SINTSintx TechnologiesMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSTGBiostageN/AN/AN/AN/A($0.26) per shareN/AINVOINVO Bioscience$3.02M0.89N/AN/A($2.06) per share-0.48MOTSMotus GI$319K1.26N/AN/A$1.74 per share0.05SINTSintx Technologies$1.23M0.68N/AN/A$1.65 per share0.02Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSTGBiostage-$6.07M-$0.58N/A∞N/AN/AN/A-174.43%N/AINVOINVO Bioscience-$8.03M-$12.36N/A∞N/A-459.42%N/A-88.87%5/20/2024 (Estimated)MOTSMotus GI-$12.87M-$28.55N/A∞N/A-4,033.54%N/A-110.70%5/8/2024 (Estimated)SINTSintx Technologies-$8.26M-$3.42N/A∞N/A-314.39%-67.12%-45.49%5/20/2024 (Estimated)Latest MOTS, INVO, BSTG, and SINT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2024Q4 2023SINTSintx TechnologiesN/A-$0.09-$0.09-$0.09N/A$0.90 million3/18/2024Q4 2023MOTSMotus GIN/A-$4.13-$4.13-$3.78N/A$0.06 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSTGBiostageN/AN/AN/AN/AN/AINVOINVO BioscienceN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSTGBiostageN/A2.732.73INVOINVO Bioscience2.940.150.12MOTSMotus GI0.461.761.69SINTSintx TechnologiesN/A1.901.60OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSTGBiostageN/AINVOINVO Bioscience12.02%MOTSMotus GI20.06%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipBSTGBiostage15.30%INVOINVO Bioscience3.50%MOTSMotus GI1.57%SINTSintx Technologies1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBSTGBiostage713.88 million11.76 millionNot OptionableINVOINVO Bioscience152.74 million2.65 millionNo DataMOTSMotus GI155.03 million4.95 millionNot OptionableSINTSintx Technologies4122.68 million22.45 millionNot OptionableMOTS, INVO, BSTG, and SINT HeadlinesSourceHeadlineWhy SINTX Technologies Stock Is Getting Hammeredmsn.com - April 3 at 2:48 PMSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stockglobenewswire.com - April 3 at 9:00 AMWhy SINTX Technologies Stock Hit A New All-Time Low Todaymsn.com - April 1 at 3:51 PMDDC Appoints Vice President to Drive Operational Excellenceitnewsonline.com - March 30 at 6:23 PMSINTX Technologies Announces Proposed Public Offering of Common Stockglobenewswire.com - March 29 at 4:00 PMSINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 28 at 7:02 AMSintx Technologies Prices Public Offering Of $1.3 Mln Of Sharesmarkets.businessinsider.com - March 25 at 1:22 PMWhy SINTX Technologies Stock Is Down 50%msn.com - March 25 at 1:22 PMWhy Is Sintx Technologies (SINT) Stock Down 31% Today?investorplace.com - March 25 at 9:05 AMSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stockglobenewswire.com - March 25 at 9:00 AMUS Stocks Edge Lower; FedEx Posts Upbeat Earningsmsn.com - March 23 at 3:15 AMWhy SINTX Technologies Is Trading Higher Todayaol.com - March 22 at 10:14 PMGold Moves Lower; Lululemon Shares Plummetmsn.com - March 22 at 5:14 PMDow Dips 200 Points; Nike Shares Fall After Q3 Resultsmarkets.businessinsider.com - March 22 at 5:14 PMSINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%markets.businessinsider.com - March 22 at 5:14 PMWhy SINTX Technologies Stock Is Nosedivingmsn.com - March 22 at 5:14 PMSINTX Technologies Announces Proposed Public Offering of Common Stockglobenewswire.com - March 22 at 8:30 AMSintx Technologies (SINT) Price Target Increased by 42.86% to 10.20msn.com - February 24 at 2:14 PMTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)benzinga.com - February 23 at 7:50 AMSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETfinance.yahoo.com - February 21 at 3:58 PMSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETglobenewswire.com - February 21 at 9:00 AMSINTX Technologies: Other Eventscbonds.com - February 16 at 10:37 AMSINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturingtctmagazine.com - February 7 at 10:57 AMSintx Technologies just downgraded at Maxim, here's whyrealmoney.thestreet.com - February 5 at 5:59 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsBiostageOTCMKTS:BSTGBiostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.INVO BioscienceNASDAQ:INVOINVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.Motus GINASDAQ:MOTSMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Sintx TechnologiesNASDAQ:SINTSintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
